Skip to main content
. 2015 May 27;6(26):22776–22798. doi: 10.18632/oncotarget.4309

Figure 9. Flow cytometry analysis of the anti-CD133 antibody delivered with nanotubes.

Figure 9

A.– 5.4% of positively labeled cells (gate P3). B. – Positively labeled cells (red) are small in size and have low granularity.